By using this calculator you agree with the following
License and Diclaimer
The provided programs implements the EORTC Scoring System for newly diagnosed Glioblastoma
as published in the paper:
Gorlia T, van den Bent MJ, Hegi ME, Mirimanoff RO, Weller M,
Cairncross JG, Eisenhauer E, Belanger K, Brandes AA, Allgeier A, Lacombe D,
Stupp R. Nomograms for predicting survival of patients with newly diagnosed
glioblastoma: prognostic factor analysis of EORTC and NCIC trial
26981-22981/CE.3.
Lancet Oncol. 2007 Dec 12
They allow the user to estimate the median survival and the probability of survival
at 2 years in patients with newly diagnosed Glioblastoma based on 7different prognostic
factors:
Therapy administered, Age, Extent of surgery, Mini Mental Score Examination,
Administration
of corticosteroids, WHO Performance Status, MGMT promoter methylation status
Please select one of the models
- Model1 : In the general GBM population
- Model2 : In patients treated by RT/TMZ (MGMT methylation
status unavailable)
- Model3 : In patients with partial or total resection and
treated by RT/TMZ (MGMT methylation status available)